Sigma-Aldrich (SIAL) Tops Q2 View; Raises FY08 EPS Outlook
More News related to SIAL
- Sigma-Aldrich (SIAL) Declares $0.145 Quarterly Dividend; 1% Yield
- Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
- Sigma-Aldrich Enters Distribution Agreement With Stemgent, Inc. to Offer Lentivirus-Based Gene Delivery Products for Regenerative Medicine and Stem Cell Research
- Sigma-Aldrich (SIAL) Announces Agreement to Manufactured and Commercialize Zip Nucleic Acid
- Sigma-Aldrich Signs License Agreement With Polyplus-transfection to Offer Novel ZNA(TM) Oligonucleotides
More News related to Earnings
- Ctrip.com (CTRP) Posts Q3 adj.-EPS of $0.44, Tops Views; Guides Q409 Revs
- Hill-Rom (HRC) Tops Q4 Views; Guides FY10
- Green Mountain Coffee (GMCR) Serves Up Great Quarter, But Traders "Sell The News"
- LJ Int'l (JADE) Reports Q3 EPS of $0.05; Guides Q4, FY09
- Magellan Petroleum (MPET) Posts Q3 Loss of $0.03, Lower Y/Y; Revs Down
Sigma-Aldrich Corporation (Nasdaq: SIAL) reports Q2 EPS of $0.70, 3 cents better than the analyst estimate of $0.67. Revenues for the quarter were $580.7 million, versus the consensus of $579.27 million.
Raises FY08 EPS guidance from $2.57-$2.67 to $2.62-$2.72, versus the consensus of $2.65.
Sigma-Aldrich Corporation, together with its subsidiaries, engages in the development, manufacture, and distribution of various biochemicals and organic chemicals worldwide.
Related Categories
EarningsGuidance
Stocks Mentioned
+0.06Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
